Viridien
Short position disclosed on October 21, 2026.
Evolution of the disclosed total
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| October 3, 2023 | Qube Research & Technologies Limited | 1.90% | March 4, 2024 | |
| October 3, 2023 | POINT72 Asset Management, L.P. | 0.88% | November 9, 2023 | AMF |
| October 2, 2023 | Qube Research & Technologies Limited | 1.82% | March 4, 2024 | |
| October 2, 2023 | POINT72 Asset Management, L.P. | 0.90% | November 9, 2023 | AMF |
| September 28, 2023 | Qube Research & Technologies Limited | 1.76% | March 4, 2024 | |
| September 26, 2023 | Qube Research & Technologies Limited | 1.60% | March 4, 2024 | |
| September 26, 2023 | Marshall Wace LLP | 0.87% | March 24, 2025 | |
| September 25, 2023 | Marshall Wace LLP | 0.91% | March 24, 2025 | |
| September 22, 2023 | Qube Research & Technologies Limited | 1.53% | March 4, 2024 | |
| September 22, 2023 | POINT72 Asset Management, L.P. | 0.82% | November 9, 2023 | AMF |
| September 21, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 | |
| September 19, 2023 | POINT72 Asset Management, L.P. | 0.70% | November 9, 2023 | AMF |
| September 18, 2023 | Qube Research & Technologies Limited | 1.09% | March 4, 2024 | |
| September 18, 2023 | Marshall Wace LLP | 0.82% | March 24, 2025 | |
| September 18, 2023 | Citadel Advisors LLC | 0.47% | September 20, 2023 | |
| September 15, 2023 | Qube Research & Technologies Limited | 1.28% | March 4, 2024 | |
| September 15, 2023 | Marshall Wace LLP | 0.71% | March 24, 2025 | |
| September 14, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 | |
| September 13, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 | |
| September 13, 2023 | POINT72 Asset Management, L.P. | 0.60% | November 9, 2023 | AMF |
| September 8, 2023 | Qube Research & Technologies Limited | 1.39% | March 4, 2024 | |
| September 6, 2023 | Marshall Wace LLP | 0.66% | March 24, 2025 | |
| September 6, 2023 | POINT72 Asset Management, L.P. | 0.52% | November 9, 2023 | AMF |
| September 5, 2023 | Qube Research & Technologies Limited | 1.49% | March 4, 2024 | |
| September 5, 2023 | Marshall Wace LLP | 0.70% | March 24, 2025 | |
| September 4, 2023 | Qube Research & Technologies Limited | 1.59% | March 4, 2024 | |
| September 1, 2023 | Qube Research & Technologies Limited | 1.60% | March 4, 2024 | |
| August 31, 2023 | Citadel Advisors LLC | 0.69% | September 20, 2023 | |
| August 30, 2023 | Qube Research & Technologies Limited | 1.73% | March 4, 2024 | |
| August 30, 2023 | Marshall Wace LLP | 0.62% | March 24, 2025 | |
| August 25, 2023 | Citadel Advisors LLC | 0.78% | September 20, 2023 | |
| August 24, 2023 | Citadel Advisors LLC | 0.80% | September 20, 2023 | |
| August 23, 2023 | Qube Research & Technologies Limited | 1.84% | March 4, 2024 | |
| August 22, 2023 | Qube Research & Technologies Limited | 1.78% | March 4, 2024 | |
| August 21, 2023 | Qube Research & Technologies Limited | 1.82% | March 4, 2024 | |
| August 17, 2023 | Citadel Advisors LLC | 0.79% | September 20, 2023 | |
| August 17, 2023 | Marshall Wace LLP | 0.53% | March 24, 2025 | |
| August 17, 2023 | Hrteu Limited | 0.46% | August 21, 2023 | |
| August 16, 2023 | Qube Research & Technologies Limited | 1.95% | March 4, 2024 | |
| August 16, 2023 | Hrteu Limited | 0.51% | August 21, 2023 | |
| August 15, 2023 | Qube Research & Technologies Limited | 2.01% | March 4, 2024 | |
| August 14, 2023 | Hrteu Limited | 0.49% | August 16, 2023 | |
| August 11, 2023 | Qube Research & Technologies Limited | 1.97% | March 4, 2024 | |
| August 11, 2023 | Marshall Wace LLP | 0.46% | August 15, 2023 | |
| August 10, 2023 | Qube Research & Technologies Limited | 2.11% | March 4, 2024 | |
| August 10, 2023 | Citadel Advisors LLC | 0.87% | September 20, 2023 | |
| August 10, 2023 | Marshall Wace LLP | 0.54% | August 15, 2023 | |
| August 10, 2023 | Systematica Investments Limited | 0.49% | August 14, 2023 | |
| August 9, 2023 | Qube Research & Technologies Limited | 2.08% | March 4, 2024 | |
| August 8, 2023 | Qube Research & Technologies Limited | 2.20% | March 4, 2024 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=13